Fulcrum Therapeutics interim CEO Robert Gould (L) and former CEO Bryan Stuart
Fulcrum CEO leaves for new opportunity, company starts search for replacement
Rare disease biotech Fulcrum Therapeutics’ CEO Bryan Stuart has stepped down to “pursue other opportunities,” the company announced.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
